RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Jerry, Thanks. So I assume someone other than Samyang, and not a pharma. Instead, it would presumably be a private investment outfit/private equity who will get a good size chunk of the company in return? That would make some sense, since raising money that way could be quicker than doing a deal for ex-US ADHD rights with a pharma (and an ex-US ADHD pharma deal might not provide enough in upfronts anyway).

As for SA, your sources indicate the delay is due to the complexity of the data, and a consultant's need for a software program to analyze it? Having to hire an SA consultant to help with the analysis would make sense.

Thanks for the info.